On March 29, 2022 Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, reported that it will be participating in the Lytham Partners Spring 2022 Investor Conference, via presentation and panel discussion (Press release, Delcath Systems, MAR 29, 2022, View Source [SID1234611104]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation
April 4, 2022, at 11:00am ET
Webcast link: View Source

Panel Discussion – Latest Technologies to Combat Cancer

April 5, 2022, at 2:00pm ET
Webcast link: View Source
Management will be participating in virtual one-on-one meetings throughout the event. To arrange a meeting with management, please contact Lytham Partners at 1×[email protected] or register at www.lythampartners.com/spring2022invreg.